Actively Recruiting
Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors
Led by University of Maryland, Baltimore · Updated on 2025-12-23
24
Participants Needed
1
Research Sites
160 weeks
Total Duration
On this page
Sponsors
U
University of Maryland, Baltimore
Lead Sponsor
U
University of Maryland, College Park
Collaborating Sponsor
AI-Summary
What this Trial Is About
Obesity can pose significant challenges to maintaining long-term health in cancer survivors by increasing their risk of cancer coming back. Eating a healthy diet is an important way to help manage weight and improve overall health. Broccoli microgreens (BMG) are young broccoli plants packed with nutrients, and research suggests they may help prevent cancer. Previous studies in mice showed that BMG can improve gut health and metabolism, leading to better health outcomes in obese animals. This study will test whether BMG can be a useful addition to the diet of obese breast cancer (BC) survivors who have a higher risk of their cancer returning. 24 obese BC survivors will be invited to eat one serving (one cup, \~57 gram) of fresh BMG every day for two weeks. This will help understand if people can stick to this diet, how their bodies respond, and whether it affects metabolism and inflammation-two key factors linked to cancer risk. Biological markers such as body fat, glucose and lipids as well as gut bacterial changes will be analyzed to see how BMG affects individual health. This study may help create new diet strategies to improve health, reduce cancer risk, and support long-term recovery in cancer patients who are overweight or obese. In the future, this research could help doctors personalize nutrition plans to better support cancer survivors.
CONDITIONS
Official Title
Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female
- Diagnosed with breast cancer (Stage I-III)
- 2 to 60 months post-curative treatment including surgery, chemotherapy, and/or radiation
- Body mass index (BMI) greater than 30 kg/m² (obese classification)
- Willing to avoid cruciferous vegetables during the study
- Able to sign an IRB-approved consent form
You will not qualify if you...
- Contraindications to the nutrition intervention as identified by a medical provider or study team (e.g., gastrointestinal conditions, medication needs, pregnancy, breastfeeding, recent eating disorder)
- Allergy or intolerance to cruciferous vegetables
- Currently taking broccoli extract supplements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Breast Evaluation and Treatment Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
Baltimore, Maryland, United States, 21201
Actively Recruiting
Research Team
Y
Yuanyuan (Rose) Li, M.D., Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here